Ovid Therapeutics
OVID
OVID
55 hedge funds and large institutions have $74.5M invested in Ovid Therapeutics in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 24 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 24
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
55
Holding in Top 10
–
Calls
$116K
Puts
–
Top Buyers
| 1 | +$6.2M | |
| 2 | +$2.11M | |
| 3 | +$1.32M | |
| 4 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$148K |
| 5 |
Renaissance Technologies
New York
|
+$83.8K |
Top Sellers
| 1 | -$4.1M | |
| 2 | -$2.48M | |
| 3 | -$1.57M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.56M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$967K |